Skip to content
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Psychiatry

What Are the Psychiatric Symptoms of Wilson Disease?

At a Glance

Wilson disease can cause severe psychiatric symptoms like depression, anxiety, and psychosis due to copper buildup in the brain. Because it mimics common mental health disorders, it is often misdiagnosed, but targeted anti-copper treatment can stop and even reverse these symptoms.

Yes, severe depression, anxiety, and other psychiatric symptoms can definitely be caused by Wilson disease. In fact, for many people, mental health struggles are the very first sign that something is physically wrong. Because Wilson disease impairs the body’s ability to process copper, this metal can build up in the brain, causing significant mood and behavioral changes that are frequently mistaken for primary psychiatric conditions like bipolar disorder, major depression, or schizophrenia [1][2].

How Copper Affects the Brain

Wilson disease is a genetic condition that prevents the liver from properly removing (or excreting) copper from your body [3]. As copper overflows into the bloodstream, it accumulates in other organs, particularly the brain [4]. This toxic buildup disrupts normal neurological function, leading to a wide range of psychiatric symptoms [2].

The most common psychiatric manifestations include:

  • Severe depression and anxiety: Major depressive disorder is highly prevalent in people with Wilson disease [5].
  • Personality and behavioral changes: You might experience sudden irritability, aggression, disinhibition, or intense mood swings [2][6].
  • Psychosis: In some cases, copper toxicity can cause delusions or hallucinations, leading to an initial misdiagnosis of schizophrenia [7][8].

Why It Is Frequently Misdiagnosed

Because the psychiatric symptoms of Wilson disease look identical to primary mental health conditions on the surface, misdiagnosis is incredibly common. Up to two-thirds of Wilson disease cases may initially be misdiagnosed [9].

Patients whose first symptoms are psychiatric face the longest diagnostic delays—sometimes taking up to five years to get a correct diagnosis [10][11]. During this time, the true cause (copper toxicity) goes untreated, which increases the risk of long-term neurological damage [12]. However, there is hope: starting anti-copper treatment can halt this progression and often significantly improves or even reverses many psychiatric and neurological symptoms [13][14].

Red Flags: Spotting the Difference

To distinguish Wilson disease from standard psychiatric conditions, doctors look for specific clinical “red flags.” If you are experiencing severe mental health symptoms, pay attention to these subtle clues:

  • Unusual reactions to psychiatric medications: People with Wilson disease are highly sensitive to standard antipsychotic medications. They may experience severe extrapyramidal symptoms (extreme muscle stiffness, tremors, or involuntary movements) when taking these drugs [1][15].
  • Subtle physical changes: Psychiatric symptoms are often accompanied by early neurological signs like mild tremors, clumsiness, changes in handwriting, or dysarthria (slurred or slow speech) [1].
  • Mild liver enzyme elevations: Even if you have no obvious liver symptoms, routine blood work might show mildly elevated liver enzymes (AST or ALT) [1][16].
  • Kayser-Fleischer rings: These are brownish or grayish rings around the edge of the cornea in the eye, caused by copper deposits. They do not affect your vision, but a special slit-lamp eye exam is usually needed to see them [1][17]. They are very common in patients with neuropsychiatric Wilson disease, though their absence does not completely rule out the condition [18].
  • Family history clues: A lack of a strong family history of mental illness, especially if paired with siblings who have unexplained liver issues, can point toward a genetic metabolic disorder rather than a primary psychiatric one [19].

Getting the Right Tests

Standard psychiatric treatments alone will not stop the underlying damage caused by Wilson disease; your body needs specific therapies to remove the excess copper [12][20]. Once copper levels are effectively lowered, many patients find that their depression, anxiety, or mood instability significantly improves [13].

If you suspect your mental health symptoms might be linked to Wilson disease, it is critical to request a comprehensive medical evaluation. Psychiatrists are primarily trained to treat mental illness, so you may need to politely ask them to coordinate with a neurologist or hepatologist (liver specialist) to investigate these physical red flags.

The evaluation should include:

  • Standard copper tests: First-line tests usually include checking serum ceruloplasmin (a protein that carries copper in the blood) and a 24-hour urine copper test to measure how much copper your body is releasing [21].
  • Advanced copper tests: In some cases, your doctor may also order specialized tests like Relative Exchangeable Copper (REC), which is highly accurate for diagnosis [22].
  • Eye exam: A referral to an ophthalmologist for a slit-lamp exam to check for Kayser-Fleischer rings [17].

Common questions in this guide

Can Wilson disease cause depression and anxiety?
Yes, severe depression and anxiety are highly common in people with Wilson disease. Because the body cannot process copper properly, the metal builds up in the brain and disrupts normal neurological function, leading to significant mood changes.
Why is Wilson disease often misdiagnosed as schizophrenia or bipolar disorder?
The psychiatric symptoms of Wilson disease, such as psychosis, delusions, and intense mood swings, look identical to primary mental health conditions on the surface. This causes up to two-thirds of cases to initially be misdiagnosed by psychiatrists.
What are the physical red flags that accompany psychiatric symptoms in Wilson disease?
Psychiatric symptoms are often accompanied by early neurological signs like mild tremors, clumsiness, and slurred speech. Patients may also have mildly elevated liver enzymes or experience severe involuntary muscle movements when taking standard antipsychotic medications.
What tests are used to diagnose Wilson disease if I have psychiatric symptoms?
Doctors typically start with a serum ceruloplasmin blood test and a 24-hour urine copper test. You may also need a slit-lamp eye exam by an ophthalmologist to look for Kayser-Fleischer rings, which are copper deposits in the cornea.
Will psychiatric medications cure the mental health symptoms of Wilson disease?
No, standard psychiatric medications do not address the underlying copper toxicity causing the symptoms. The body requires specific anti-copper therapies to remove the excess metal, which often significantly improves or reverses the psychiatric issues.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my psychiatric symptoms and [mention physical symptoms like tremors or liver enzyme levels], could we explore testing for a metabolic condition like Wilson disease?
  2. 2.Can we order a serum ceruloplasmin blood test and a 24-hour urine copper test to rule out copper toxicity?
  3. 3.Would you be willing to coordinate with a neurologist or hepatologist to evaluate my symptoms comprehensively?
  4. 4.Could I get a referral to an ophthalmologist for a slit-lamp exam to check for Kayser-Fleischer rings?
  5. 5.If I need psychiatric medication in the meantime, how can we avoid drugs that might trigger severe neurological side effects if I do have a copper processing issue?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    Wilson Disease Hiding in Plain Sight: A Case Report of Psychosis and Catatonia Revealing Underlying Liver Dysfunction.

    Buciuc AG, Padilla V, Durand D, Zelde E

    Reports (MDPI) 2025; (8(4)) doi:10.3390/reports8040261.

    PMID: 41441537
  2. 2

    Addressing Psychiatric Symptoms in Wilson's Disease: Translational Overlap with Bipolar Disorder and Emerging Therapeutic Strategies.

    Carta MG, Zimbrean PC, Fantini MC, Primavera D

    Journal of clinical medicine 2025; (14(16)) doi:10.3390/jcm14165866.

    PMID: 40869692
  3. 3

    Wilson disease.

    Członkowska A, Litwin T, Dusek P, et al.

    Nature reviews. Disease primers 2018; (4(1)):21 doi:10.1038/s41572-018-0018-3.

    PMID: 30190489
  4. 4

    Effect of primary copper metabolism disturbance on elemental, protein, and lipid composition of the organs in Jackson toxic milk mouse.

    Hadrian K, Szczerbowska-Boruchowska M, Surówka A, et al.

    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine 2025; (38(1)):103-121 doi:10.1007/s10534-024-00640-y.

    PMID: 39365499
  5. 5

    Major Depressive Disorder in an International Multisite Wilson Disease Registry.

    Camarata MA, Ala A, Coskun AK, et al.

    Journal of the Academy of Consultation-Liaison Psychiatry 2023; (64(2)):106-117 doi:10.1016/j.jaclp.2022.12.001.

    PMID: 36521682
  6. 6

    Psychiatric comorbidity in Wilson's disease.

    Mura G, Zimbrean PC, Demelia L, Carta MG

    International review of psychiatry (Abingdon, England) 2017; (29(5)):445-462 doi:10.1080/09540261.2017.1311845.

    PMID: 28681670
  7. 7

    Psychiatric Symptoms in Wilson's Disease-Consequence of ATP7B Gene Mutations or Just Coincidence?-Possible Causal Cascades and Molecular Pathways.

    Gromadzka G, Antos A, Sorysz Z, Litwin T

    International journal of molecular sciences 2024; (25(22)) doi:10.3390/ijms252212354.

    PMID: 39596417
  8. 8

    Wilson's Disease Preceded by Schizophrenia-like Symptoms with Frontal-dominant Leukoencephalopathy.

    Miyano R, Mitsutake A, Matsukawa T, et al.

    Internal medicine (Tokyo, Japan) 2025; (64(14)):2240-2244 doi:10.2169/internalmedicine.4353-24.

    PMID: 39662915
  9. 9

    Wilson's Disease Update: An Indian Perspective.

    Kumar N, Prashant LK, Goyal V

    Annals of Indian Academy of Neurology 2021; (24(5)):652-663 doi:10.4103/aian.AIAN_171_21.

    PMID: 35002122
  10. 10

    Clinical Determinants and Prognostic Impact of Delayed Diagnosis in Wilson's Disease.

    Antos A, Niewada M, Kraiński Ł, Członkowska A

    Diagnostics (Basel, Switzerland) 2025; (15(18)) doi:10.3390/diagnostics15182358.

    PMID: 41008730
  11. 11

    Wilson disease and psychiatric symptoms: A brief case report.

    Guerrero-Jiménez M, Carrillo de Albornoz Calahorro CM, Gutierrez Rojas L

    General psychiatry 2019; (32(3)):e100066 doi:10.1136/gpsych-2019-100066.

    PMID: 31423476
  12. 12

    Neurologic impairment in Wilson disease.

    Dusek P, Litwin T, Członkowska A

    Annals of translational medicine 2019; (7(Suppl 2)):S64 doi:10.21037/atm.2019.02.43.

    PMID: 31179301
  13. 13

    Influence of Liver Transplantation on Neuropsychiatric Manifestations of Wilson Disease.

    Yagci MA, Tardu A, Karagul S, et al.

    Transplantation proceedings 2015; (47(5)):1469-73.

    PMID: 26093745
  14. 14

    Does Liver Transplant Improve Neurological Symptoms in Wilson Disease? Report of 24 Cases.

    Aksoy F, Arslan İE, Ozgur T, et al.

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2022; (20(11)):1009-1015 doi:10.6002/ect.2022.0206.

    PMID: 36524887
  15. 15

    Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment.

    Litwin T, Dusek P, Szafrański T, et al.

    Therapeutic advances in psychopharmacology 2018; (8(7)):199-211 doi:10.1177/2045125318759461.

    PMID: 29977520
  16. 16

    Clinical manifestations of Wilson disease in organs other than the liver and brain.

    Dzieżyc-Jaworska K, Litwin T, Członkowska A

    Annals of translational medicine 2019; (7(Suppl 2)):S62 doi:10.21037/atm.2019.03.30.

    PMID: 31179299
  17. 17

    Kayser-Fleischer rings: The pathognomonic for Wilson's disease.

    Singh P, Subedi B, Mahato D, Karn M

    Clinical case reports 2024; (12(3)):e8642 doi:10.1002/ccr3.8642.

    PMID: 38464582
  18. 18

    Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson's Disease.

    Dong Y, Wang RM, Yang GM, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021; (19(3)):590-596 doi:10.1016/j.cgh.2020.05.044.

    PMID: 32485301
  19. 19

    Familial screening of children with Wilson disease: Necessity of screening in previous generation and screening methods.

    Li H, Liu L, Li Y, et al.

    Medicine 2018; (97(27)):e11405 doi:10.1097/MD.0000000000011405.

    PMID: 29979436
  20. 20

    Tackling the neurological manifestations in Wilson's disease - currently available treatment options.

    Litwin T, Dusek P, Antos A, et al.

    Expert review of neurotherapeutics 2023; (23(12)):1249-1259 doi:10.1080/14737175.2023.2268841.

    PMID: 37842984
  21. 21

    Clinical presentations of Wilson disease among Polish children.

    Naorniakowska M, Dądalski M, Kamińska D, et al.

    Developmental period medicine 2016; (20(3)):216-221.

    PMID: 27941192
  22. 22

    Relative exchangeable copper: A highly specific and sensitive biomarker for Wilson disease diagnosis.

    Djebrani-Oussedik N, Desjardins C, Obadia MA, et al.

    JHEP reports : innovation in hepatology 2025; (7(10)):101537 doi:10.1016/j.jhepr.2025.101537.

    PMID: 40980162

This page provides educational information about the psychiatric manifestations of Wilson disease. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with a healthcare provider if you are experiencing severe mental health or neurological symptoms.

Get notified when new evidence is published on Wilson disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.